Patient privacy safeguards are woefully missing from initial draft criteria for Stages 2 and 3 of meaningful use, according to Deborah Peel, M.D., founder of the Patient Privacy Rights organization.

"Like the criteria for Stage 1, the criteria for Meaningful Use Stage 2 and 3 are missing the key elements Americans expect from electronic systems: the ability to control who can see and use personal health information and the ability to segment information so they can selectively share information," Peel said in a comment letter to the Office of the National Coordinator. "Segmentation is essential to protect sensitive information, but also is absolutely critical for patient safety, so that erroneous health information can be kept from disclosure."

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access